Edition:
United Kingdom

ZIOPHARM Oncology Inc (ZIOP.OQ)

ZIOP.OQ on NASDAQ Stock Exchange Capital Market

3.83USD
16 Feb 2018
Change (% chg)

$-0.05 (-1.29%)
Prev Close
$3.88
Open
$3.87
Day's High
$3.94
Day's Low
$3.81
Volume
201,000
Avg. Vol
392,477
52-wk High
$7.88
52-wk Low
$3.33

Chart for

About

ZIOPHARM Oncology, Inc. is a biopharmaceutical company, which is seeking to develop, acquire and commercialize, on its own or with partners, a portfolio of cancer therapies that address unmet medical needs. The Company is focused on developing products in immuno-oncology that employ gene expression, control and cell technologies... (more)

Overall

Beta: 1.54
Market Cap(Mil.): $890.11
Shares Outstanding(Mil.): 141.96
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 83.93 16.64
EPS (TTM): -- -- --
ROI: -- 1.66 10.66
ROE: -- 2.58 14.30

BRIEF-Ziopharm Oncology Addresses Rumors And Stock Volatility, Affirms 2018 Guidance

* ZIOPHARM ONCOLOGY ADDRESSES RUMORS AND STOCK VOLATILITY, AFFIRMS 2018 GUIDANCE

06 Feb 2018

BRIEF-Ziopharm Oncology To Initiate Pivotal Trial Of Cancer Treatment in Second Half of 2018

* ZIOPHARM ONCOLOGY PROVIDES UPDATE ON STANDOUT TECHNOLOGIES DURING THE 36TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

09 Jan 2018

BRIEF-Ziopharm Oncology reports third quarter financial results

* Ziopharm Oncology reports third quarter 2017 financial results and provides update on recent activities

06 Nov 2017

Earnings vs. Estimates